The creator of SensDx is Dawid Nidzworski, Doctor of Biological Sciences specialising in Biochemistry, who, together with Artur Kupczunas, Piotr Krych and Tomasz Gondek, established SensDx (formerly Eton Group) in September 2014
Victory (1st place) in the Architects of Innovation competition, organized by the editors of Puls Biznesu, in the category of Emerging Technologies.
Victory (1st place) Eagles of Startup Innovation competition, organized by the editors of the Rzeczpospolita daily, in the breakthrough technology category.
SensDx, as one of 16 companies from around the world (only 3 from Poland) in the Medica Start-up Zone at MEDICA 2018- World Forum of Medicine, the largest and most important event in the medical industry in Europe.
Presentation of SensDx during the European Forum for New Ideas 2018
Presentation of SensDx at the prestigious 8th International Conference on Epidemiology & Public Health, Rome 2018
First place for SensDx in the Future Diagnostics category at the Roche Innovation Summit 2018
Nomination in the competition of the Focus magazine “Soczewki Focus” 2018, in the medical innovations category
SensDx was chosen as one of the three best startups on Demo Day Impact Poland 2018
SensDx presentation at the Start-Up Academy Medtec Europe 2018
Presentation of SensDx during MedForce Berlin 2018
Main Prize in the EIT Health InnoStars Awards 2017
The article of our scientists was published in Scientific Reports from the Nature Group and was selected for the TOP 100 in 2017
SensDx was at one of the largest and most important trade fairs of the MedTech industry in Europe – MEDICA 2017
SensDx was presented at one of the largest and most important trade fairs of the MedTech industry in Asia – Asia Pacific MedTech Forum 2017
SensDx is the laureate of the SME phase 1 – H2020 project in 2017 for small and medium enterprise